Wende Hutton
Angel · California
Board director at 5 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Seed to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Oct 2024
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: Antiva BiosciencesMay 5, 2023
- SEC Form D: OncoResponseMay 12, 2023
- SEC Form D: GlookoAug 18, 2023
- SEC Form D: Qlaris BioApr 22, 2024
- SEC Form D: Hyalex OrthopaedicsOct 2, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.